A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
Clinical trial NCT05047601 · COMPLETED
Trial details
- NCT number
- NCT05047601
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-09
- Primary completion
- 2022-04-12
- Enrollment
- 2954
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.